Is Lidocaine Safe During Pregnancy
Status
cautionReason
Pregnancy data are reassuring, but use only when needed and dose must be set by your provider.
Drug Information
Safe Amount
Dosage must be determined by your provider based on individual risk/benefit. Official labeling for lidocaine injection lists a maximum of 4.5 mg/kg (300 mg) plain or 7 mg/kg (500 mg) with epinephrine.
Effects
- Pregnancy
- Official labeling reports no identified drug-related risk in human data, but placental transfer occurs and dose matters.
- Mother
- May cause local numbness, and high doses can cause toxicity or allergic-type reactions.
- Baby
- Crosses the placenta; high doses or accidental injection may cause fetal heart or nervous system effects.
Trimester Notes
- 1st Trimester
- Use only if clearly needed, especially during organ development.
- 2nd Trimester
- May be used when benefits outweigh risks; lowest effective dose is preferred.
- 3rd Trimester
- May be used if needed; provider should avoid high doses and monitor closely.
Risk-Benefit Note
For needed procedures, treating pain or infection may be better than delaying care. Your prescriber should decide if lidocaine is appropriate for your situation.
Conditions & Warnings
- Consult OB/GYN or prescriber
- Dose and route must be reviewed by a provider
- Use with caution if you have liver disease or heart rhythm problems
- If dental or minor procedure use is needed, provider should use the lowest effective dose
- Do not stop or start prescription treatment without prescriber guidance
Alternatives
- Non-drug measures when appropriate
- Provider-selected local anesthetic with the lowest effective dose
- Acetaminophen for pain if your OB/GYN says it is appropriate
References
- FDA DailyMed / labeling for lidocaine
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022114s006lbl.pdf - FDA DailyMed / labeling for Xylocaine
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006488s097lbl.pdf - FDA DailyMed / labeling for Xylocaine-MPF
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/006488s095_s090lbl.pdf